Published • loading... • Updated
7 Million Doses for SUS: Maringá Factory Is Preparing to Produce Vaccine Against Highly Contagious Disease; Understand
Summary by Portal GMC Online
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The Institute of Paraná Technology (Tecpar) submitted to the National Agency of Health Surveillance (Anvisa) the application to register [...]
Maringá may become one of the main centers of vaccine production in Brazil. The Institute of Paraná Technology...
The Institute of Paraná Technology (Tecpar) asked Anvisa to register the vaccine against chickenpox, catapore. The forecast is to provide 7 million doses to SUS in 2027, with vaccine imported from Sinovac and then national production in Maringá.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
